Search

Displaying results 5581 - 5590 of 8412 in total
  1. Drug

    Bucloxic acid

    go.drugbank.com/drugs/DB20877
    Experimental

    Bucloxic acid has a monoisotopic molecular weight of 294.1 Da.

  2. Drug

    Sorbitan monostearate

    go.drugbank.com/drugs/DB20996
    Experimental

    Sorbitan monostearate has a monoisotopic molecular weight of 430.33 Da.

  3. Drug

    Furacrinic acid

    go.drugbank.com/drugs/DB21223
    Experimental

    Furacrinic acid has a monoisotopic molecular weight of 258.09 Da.

  4. Drug

    Xantofyl palmitate

    go.drugbank.com/drugs/DB21273
    Experimental

    Xantofyl palmitate has a monoisotopic molecular weight of 1044.89 Da.

  5. Drug

    Cromoglicate lisetil

    go.drugbank.com/drugs/DB21297
    Experimental

    Cromoglicate lisetil has a monoisotopic molecular weight of 652.23 Da.

  6. Drug

    Iobutoic acid

    go.drugbank.com/drugs/DB21443
    Experimental

    Iobutoic acid has a monoisotopic molecular weight of 670.82 Da.

  7. Drug

    Terpin hydrate

    go.drugbank.com/drugs/DB13163
    ApprovedWithdrawn

    Terpin hydrate is an expectorant, commonly used to loosen mucus and ease congestion in patients presenting with acute or chronic bronchitis, and related pulmonary conditions.

    Synonyms: cis-p-methane-1,8-diol monohydrate
  8. Drug

    Prednicarbate

    go.drugbank.com/drugs/DB01130
    Approved

    It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a low potential to cause skin atrophy.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers
  9. Drug

    1alpha-Hydroxyvitamin D5

    go.drugbank.com/drugs/DB13097
    Investigational

    1alpha-Hydroxyvitamin D5 (CARD-024) has been used in trials studying the treatment of Drug Safety and Heart; Disease, Activity.

    Categories: Vitamin D and AnaloguesSynonyms: 1-Hydroxyvitamin D5
  10. Drug

    Enzalutamide d3

    go.drugbank.com/drugs/DB19123
    Investigational

    Enzalutamide d3 is under investigation in clinical trial NCT03850795 (HC-1119 Versus Enzalutamide in Metastatic Castration-resistant Prostate Cancer (Mcrpc)).

    Synonyms: Enzalutamide d3, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-n-(methyl-d3)benzamide